During the past decade, Consorci Sanitari Integral conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Consorci Sanitari Integral" are "Complication, Postoperative" (1 trials), "Mortality" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Consorci Sanitari Integral" in a lesser frequency.

Most popular intervention types in "Consorci Sanitari Integral" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Beta blocker" (1 trials) and "Surgical or non-surgical intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Consorci Sanitari Integral" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Consorci Sanitari Integral". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Consorci Sanitari Integral, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Consorci Sanitari Integral, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".